The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank
Open accessAbstract
Adenine base editing (ABE) enables enzymatic conversion from A-T into G-C base pairs. ABE holds promise for clinical application, as it does not depend on the introduction of double-strand breaks, contrary to conventional CRISPR/Cas9-mediated genome engineering. Here, we describe a cystic fibrosis (CF) intestinal organoid biobank, representing 664 patients, of which ~20% can theoretically be repaired by ABE. We apply SpCas9-ABE (PAM recognition sequence: NGG) and xCas9-ABE (PAM recognition sequence: NGN) on four selected CF organoid samples. Genetic and functional repair was obtained in all four cases, while whole-genome sequencing (WGS) of corrected lines of two patients did not detect off-target mutations. These observations exemplify the value of large, patient-derived organoid biobanks representing hereditary disease and indicate that ABE may be safely applied in human cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We have previously described the use of ABEs in Cystic Fibrosis patient-derived organoids to functionally repair mutations in CFTR without genome-wide off-targets31.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“While base editors have been applied before in organoids to model36 and repair31 diseases, we significantly extend their application by demonstrating the opportunities that reside in multiplexing CBE’s and ABE’s, as well as Cas9 homologs and evolved Cas9 variants.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R. E., Garimella, K. V., Maguire, J., Hartl, C., Philippakis, A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,457
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
Sato, T., Stange, D. E., Ferrante, M., Vries, R. G. J., van Es, J. H., van den Brink, S., van Houdt, W. J., Pronk, A., van Gorp, J., Siersema, P. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.050 · Cited by 3,753
Self-citationHigh-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Cited by
Sorted by citations
Establishment of patient-derived cancer organoids for drug-screening applications
Driehuis, E., Kretzschmar, K., & Clevers, H. C. (2020) · Nature Protocols · doi:10.1038/s41596-020-0379-4 · Cited by 685
Self-citationHuman organoids in basic research and clinical applications
Tang, X.-Y., Wu, S., Wang, D., Chu, C., Hong, Y., Tao, M., Hu, H., Xu, M., Guo, X. L., & Liu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01024-9 · Cited by 539
Organoids: The current status and biomedical applications
Yang, S., Hu, H., Kung, H., Zou, R.-Q., Dai, Y.-S., Hu, Y.-F., Wang, T., Lv, T., Yu, J., & Li, F. (2023) · MedComm · doi:10.1002/mco2.274 · Cited by 300
Establishment and Culture of Human Intestinal Organoids Derived from Adult Stem Cells
Pleguezuelos‐Manzano, C., Puschhof, J., van den Brink, S., Geurts, V., Beumer, J., & Clevers, H. C. (2020) · Current Protocols in Immunology · doi:10.1002/cpim.106 · Cited by 271
Self-citationBioengineering Approaches for the Advanced Organoid Research
Yi, S. A., Zhang, Y., Rathnam, C., Pongkulapa, T., & Lee, K. (2021) · Advanced Materials · doi:10.1002/adma.202007949 · Cited by 218
Chondrocyte-specific genomic editing enabled by hybrid exosomes for osteoarthritis treatment
Liang, Y., Xu, X., Xu, L., Iqbal, Z., Ouyang, K., Zhang, H., Wen, C., Duan, L., & Xia, J. (2022) · Theranostics · doi:10.7150/thno.69368 · Cited by 217
CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids
Hendriks, D. F. G., Clevers, H. C., & Artegiani, B. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.10.014 · Cited by 202
Self-citationApplications of organoids for cancer biology and precision medicine
Lo, Y.-H., Karlsson, K., & Kuo, C. J. (2020) · Nature Cancer · doi:10.1038/s43018-020-0102-y · Cited by 182
In vivo editing of lung stem cells for durable gene correction in mice
Sun, Y., Chatterjee, S., Lian, X., Traylor, Z., Sattiraju, S. R., Xiao, Y., Dilliard, S. A., Sung, Y., Kim, M., Lee, S. M., et al. (2024) · Science · doi:10.1126/science.adk9428 · Cited by 190
Wei, T., Sun, Y., Cheng, Q., Chatterjee, S., Traylor, Z., Johnson, L. T., Coquelin, M. L., Wang, J., Torres, M. J., Lian, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42948-2 · Cited by 207
Zhang, B. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30064 · Cited by 191
Zhou, Z., Cong, L., & Cong, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.762184 · Cited by 189
Rasul, M. F., Hussen, B. M., Salihi, A. B., Ismael, B. S., Jalal, P. J., Zanichelli, A., Jamali, E., Baniahmad, A., Ghafouri‐Fard, S., Basiri, A., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-021-01487-4 · Cited by 187
Somatic cell-derived organoids as prototypes of human epithelial tissues and diseases
Fujii, M., & Sato, T. (2020) · Nature Materials · doi:10.1038/s41563-020-0754-0 · Cited by 175
The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches
Graeber, S. Y., & Mall, M. A. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01608-2 · Cited by 147
Self-citationOrganoids in gastrointestinal diseases: From experimental models to clinical translation
Günther, C., Winner, B., Neurath, M. F., & Stappenbeck, T. S. (2022) · Gut · doi:10.1136/gutjnl-2021-326560 · Cited by 145
Future therapies for cystic fibrosis
Allen, L., Allen, L. J., Carr, S. B., Davies, G., Downey, D. G., Egan, M. E., Forton, J. T., Gray, R. D., HAWORTH, C. S., Horsley, A. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36244-2 · Cited by 148
Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids
Geurts, M. H., de Poel, E., Pleguezuelos-Manzano, C., Oka, R., Carrillo, L., Andersson-Rolf, A., Boretto, M., Brunsveld, J. E., van Boxtel, R., Beekman, J. M., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202000940 · Cited by 151
Self-citationRNA‐based medicine: from molecular mechanisms to therapy
Sparmann, A., & Vogel, J. (2023) · The EMBO Journal · doi:10.15252/embj.2023114760 · Cited by 151
Exploring the human lacrimal gland using organoids and single-cell sequencing
Bannier-Hélaouët, M., Post, Y., Korving, J., Bustos, M. T., Gehart, H., Begthel, H., Bar‐Ephraïm, Y. E., van der Vaart, J., Kalmann, R., Imhoff, S. M., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.02.024 · Cited by 134
Self-citationResearch Progress, Challenges, and Breakthroughs of Organoids as Disease Models
Huang, Y., Huang, Z., Tang, Z., Chen, Y., Huang, M., Liu, H., Huang, W., Ye, Q., & Jia, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.740574 · Cited by 134
Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope
Jiang, T., Henderson, J. M., Coote, K. J., Cheng, Y., Valley, H. C., Zhang, X.-O., Wang, Q., Rhym, L. H., Cao, Y., Newby, G. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15892-8 · Cited by 112
The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases
Abdelnour, S. A., Xie, L., Hassanin, A. A., Zuo, E., & Lu, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.699597 · Cited by 121
CRISPR engineering in organoids for gene repair and disease modelling
Geurts, M. H., & Clevers, H. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-022-00013-5 · Cited by 103
Self-citationKidney Organoids and Tubuloids
Yengej, F. A. Y., Jansen, J., Rookmaaker, M. B., Verhaar, M. C., & Clevers, H. C. (2020) · Cells · doi:10.3390/cells9061326 · Cited by 107
Self-citationYao, Q., Cheng, S., Pan, Q., Yu, J., Cao, G., Li, L., & Cao, H. (2024) · MedComm · doi:10.1002/mco2.735 · Cited by 100
Tuft cells act as regenerative stem cells in the human intestine
Huang, L., Bernink, J. H., Giladi, A., Krueger, D., van Son, G. J. F., Geurts, M. H., Busslinger, G. A., Lin, L., Begthel, H., Zandvliet, M. M. J. M., et al. (2024) · Nature · doi:10.1038/s41586-024-07952-6 · Cited by 101
Self-citationGene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing
Maule, G., Arosio, D., & Cereseto, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113903 · Cited by 102
Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges
Wang, D., Villenave, R., Stokar‐Regenscheit, N., & Clevers, H. C. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01317-y · Cited by 111
Self-citationApplications of human organoids in the personalized treatment for digestive diseases
Wang, Q., Guo, F., Jin, Y., & Ma, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01194-6 · Cited by 85
Gene therapy for cystic fibrosis: new tools for precision medicine
Lee, J. A., Cho, A., Huang, E. N., Xu, Y., Quach, H., Hu, J., & Wong, A. P. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03099-4 · Cited by 94
Readthrough compounds for nonsense mutations: bridging the translational gap
Spelier, S., van Doorn, E. P. M., van der Ent, C. K., Beekman, J. M., & Koppens, M. A. J. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.01.004 · Cited by 74
Self-citationRevolutionizing immune research with organoid-based co-culture and chip systems
Papp, D., Korcsmáros, T., & Hautefort, I. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae004 · Cited by 74
Strategies for genetic manipulation of adult stem cell-derived organoids
Menche, C., & Farin, H. F. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00609-8 · Cited by 72
Modelling of primary ciliary dyskinesia using patient-derived airway organoids
van der Vaart, J., Böttinger, L., Geurts, M. H., van de Wetering, W. J., Knoops, K., Sachs, N., Begthel, H., Korving, J., López‐Iglesias, C., Peters, P. J., et al. (2021) · EMBO Reports · doi:10.15252/embr.202052058 · Cited by 68
Self-citationRecent progress on the organoids: Techniques, advantages and applications
Liu, X., Zhou, Z., Zhang, Y., Zhong, H., Cai, X., & Guan, R. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117942 · Cited by 79
Treating Cystic Fibrosis with mRNA and CRISPR
Sanchez, A. D. S., Paunovska, K., Cristian, A., & Dahlman, J. E. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.137 · Cited by 75
Genetic engineering in organoids
Teriyapirom, I., Batista-Rocha, A. S., & Koo, B.-K. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-020-02029-z · Cited by 68
Reactive Oxygen Species in intestinal stem cell metabolism, fate and function
Morris, O., & Jasper, H. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.02.015 · Cited by 70
One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids
Geurts, M. H., Gandhi, S., Boretto, M. G., Akkerman, N., Derks, L. L. M., van Son, G., Celotti, M., Harshuk-Shabso, S., Peci, F., Begthel, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40701-3 · Cited by 66
Self-citationFunctional correction of CFTR mutations in human airway epithelial cells using adenine base editors
Krishnamurthy, S., Traore, S., Cooney, A. L., Brommel, C. M., Kulhánková, K., Sinn, P. L., Newby, G. A., Liu, D. R., & McCray, P. B. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab788 · Cited by 63
A precise and efficient adenine base editor
Tu, T., Song, Z., Liu, X., Wang, S., He, X., Xi, H., Wang, J., Yan, T., Chen, H., Zhang, Z., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.07.010 · Cited by 55
Translating Embryogenesis to Generate Organoids: Novel Approaches to Personalized Medicine
Sahu, S., & Sharan, S. K. (2020) · iScience · doi:10.1016/j.isci.2020.101485 · Cited by 52
Lyu, P., Lu, Z., Cho, S.-I., Yadav, M., Yoo, K. W., Atala, A., Kim, J., & Lu, B. (2021) · The CRISPR Journal · doi:10.1089/crispr.2020.0095 · Cited by 50
Gene therapy for cystic fibrosis: Challenges and prospects
Sui, H., Xu, X., Su, Y., Gong, Z., Yao, M., Liu, X., Zhang, T., Jiang, Z., Bai, T., Wang, J., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1015926 · Cited by 56
Biobanking of human gut organoids for translational research
Perrone, F. M., & Zilbauer, M. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00606-x · Cited by 53
Endometrial Organoids: A New Model for the Research of Endometrial-Related Diseases†
Gu, Z., Jia, S., Liu, S., & Leng, J. (2020) · Biology of Reproduction · doi:10.1093/biolre/ioaa124 · Cited by 47
Toward Gene Transfer Nanoparticles as Therapeutics
Kavanagh, E. W., & Green, J. J. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102145 · Cited by 46
Cystic Fibrosis: Overview of the Current Development Trends and Innovative Therapeutic Strategies
Almughem, F. A., Aldossary, A. M., Tawfik, E. A., Alomary, M. N., Alharbi, W. S., Alshahrani, M. Y., & Alshehri, A. A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070616 · Cited by 53
Exploiting CRISPR Cas9 in Three-Dimensional Stem Cell Cultures to Model Disease
Gopal, S., Rodrigues, A. L., & Dordick, J. S. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00692 · Cited by 46
CRISPR-based strategies for targeted transgene knock-in and gene correction
Lau, C., Tin, C., & Suh, Y. (2020) · Faculty Reviews · doi:10.12703/r/9-20 · Cited by 46
Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering
Gähwiler, E. K. N., Motta, S. E., Martin, M., Nugraha, B., Hoerstrup, S. P., & Emmert, M. Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.639699 · Cited by 42
Correction of Airway Stem Cells: Genome Editing Approaches for the Treatment of Cystic Fibrosis
King, N. E., Suzuki, S., Barillà, C., Hawkins, F. J., Randell, S. H., Reynolds, S. D., Stripp, B. R., & Davis, B. R. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.160 · Cited by 40
Cheng, Y., Wang, H., & Li, M. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108524 · Cited by 45
Shuttle peptide delivers base editor RNPs to rhesus monkey airway epithelial cells in vivo
Kulhánková, K., Traore, S., Cheng, X., Benk-Fortin, H., Hallée, S., Harvey, M., Roberge, J., Couture, F., Kohli, S., Gross, T. J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43904-w · Cited by 38
Comparison of Cas9 and Cas12a CRISPR editing methods to correct the W1282X-CFTR mutation
Santos, L., Mention, K., Cavusoglu-Doran, K., Sanz, D. J., Bacalhau, M., Lopes‐Pacheco, M., Harrison, P. T., & Farinha, C. M. (2021) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2021.05.014 · Cited by 36
CRISPR/Cas9 gene editing therapies for cystic fibrosis
Graham, C., & Hart, S. L. (2021) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2021.1869208 · Cited by 39
Silva, I. A. L., Laselva, O., & Lopes‐Pacheco, M. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12081321 · Cited by 36
Potential of helper-dependent Adenoviral vectors in CRISPR-cas9-mediated lung gene therapy
Bandara, R. A., Chen, Z. R., & Hu, J. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00662-w · Cited by 35
Amistadi, S., Maule, G., Ciciani, M., Ensinck, M. M., Keersmaecker, L. D., Ramalho, A. S., Guidone, D., Buccirossi, M., Galietta, L. J. V., Carlon, M. S., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.03.004 · Cited by 35
Interferon-responsive intestinal BEST4/CA7+ cells are targets of bacterial diarrheal toxins
Wang, D., Spoelstra, W. K., Lin, L., Akkerman, N., Krueger, D., Dayton, T. L., van Zon, J. S., Tans, S. J., van Es, J. H., & Clevers, H. C. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.02.003 · Cited by 35
Self-citationCystic fibrosis: new challenges and perspectives beyond elexacaftor/tezacaftor/ivacaftor
Terlizzi, V., & Lopes‐Pacheco, M. (2025) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666251323194 · Cited by 34
Advancements in CRISPR/Cas systems for disease treatment
Xu, Y., Le, H., Wu, Q., Wang, N., & Gong, C. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.05.007 · Cited by 35
Mizutani, T., Boretto, M., Lim, S., Drost, J., González, D. M., Oka, R., Geurts, M. H., Begthel, H., Korving, J., van Es, J. H., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00841-x · Cited by 36
Self-citationLee, D. D. H., Cardinale, D., Nigro, E., Butler, C. R., Rutman, A., Fassad, M. R., Hirst, R. A., MOULDING, D. A., Agrotis, A., Forsythe, E., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.00455-2020 · Cited by 31
PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cells
Hiramoto, T., Kashiwakura, Y., Hayakawa, M., Baatartsogt, N., Kamoshita, N., Abe, T., Inaba, H., Nishimasu, H., Uosaki, H., Hanazono, Y., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00286-w · Cited by 31
One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies
Ensinck, M. M., & Carlon, M. S. (2022) · Cells · doi:10.3390/cells11121868 · Cited by 33
Progress in Respiratory Gene Therapy
McLachlan, G., Alton, E. W. F. W., Boyd, A., Clarke, N. K., Davies, J. C., Gill, D. R., Uta Griesenbach, D., Hickmott, J. W., Hyde, S. C., Miah, K. M., et al. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.172 · Cited by 32
Epidermal growth factor receptor (EGFR) is a target of the tumor-suppressor E3 ligase FBXW7
Boretto, M., Geurts, M. H., Gandhi, S., Ma, Z., Staliarova, N., Celotti, M., Lim, S., He, G.-W., Millen, R., Driehuis, E., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2309902121 · Cited by 30
Self-citationWang, J., Wang, P., Shao, Y., & He, D. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082151 · Cited by 30
Primate Organoids and Gene-Editing Technologies toward Next-Generation Biomedical Research
Chen, C., Ji, W., & Niu, Y. (2021) · Trends in biotechnology · doi:10.1016/j.tibtech.2021.03.010 · Cited by 28
The promise of human organoids in the digestive system
Funata, M., Nio, Y., Erion, D. M., Thompson, W. L., & Takebe, T. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00661-3 · Cited by 28
On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis
Ensinck, M. M., Mottais, A., Detry, C., Leal, T., & Carlon, M. S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.662110 · Cited by 31
Chen, J., & Na, F. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1066869 · Cited by 25
Patient-derived tumor models and their distinctive applications in personalized drug therapy
He, J., Zhang, C., Özkan, A., Feng, T., Duan, P., Wang, S., Yang, X., Xie, J., & Liu, X. (2023) · Mechanobiology in Medicine · doi:10.1016/j.mbm.2023.100014 · Cited by 27
Human Organoids as an Emerging Tool for Genome Screenings
Andreatta, F., Hendriks, D. F. G., & Artegiani, B. (2025) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-103023-122327 · Cited by 24
Gene therapy strategies for rare monogenic disorders with nuclear or mitochondrial gene mutations
Wang, Y., Hu, L., Zhou, T., Qi, L., Xing, L., Lee, J., Wang, F., Oh, Y., & Jiang, H. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121108 · Cited by 25
Xu, X., Wang, S., Zhou, J., Chen, J., Huang, Y., Kumari, R., Mao, B., Zheng, M., An, X., tu, X., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0279821 · Cited by 26
Self-citationPerspectives on the translation of in-vitro studies to precision medicine in Cystic Fibrosis
Dumas, M., Xia, S., Bear, C. E., & Ratjen, F. A. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103660 · Cited by 24
Increasing the Targeting Scope of CRISPR Base Editing System Beyond NGG
Yu, S.-Y., Birkenshaw, A., Thomson, T., Carlaw, T., Zhang, L., & Ross, C. J. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0109 · Cited by 23
Prime Editing, a Novel Genome-Editing Tool That May Surpass Conventional CRISPR-Cas9
Ochoa-Sanchez, A., Perez-Sanchez, G., Torres-Ledesma, A. M., Valdez, J. P. R., Rinaldi, G., Moguel, B., & Molina‐Aguilar, C. (2021) · Re GEN Open · doi:10.1089/regen.2021.0016 · Cited by 22
CRISPR-Cas9 base editors and their current role in human therapeutics
Lahr, W. S., Sipe, C. J., Skeate, J. G., Webber, B. R., & Moriarity, B. S. (2023) · Cytotherapy · doi:10.1016/j.jcyt.2022.11.013 · Cited by 21
When synthetic biology meets medicine
Feng, Y., Su, C., Mao, G., Sun, B., Cai, Y., Dai, J., & Ma, Y. (2024) · Life Medicine · doi:10.1093/lifemedi/lnae010 · Cited by 21
New developments and applications of human organoids
Andersson-Rolf, A., & Clevers, H. C. (2026) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-026-00974-0 · Cited by 22
Self-citationProgress and challenges in CRISPR-mediated therapeutic genome editing for monogenic diseases
Konishi, C. T., & Long, C. (2021) · Journal of Biomedical Research · doi:10.7555/jbr.34.20200105 · Cited by 26
Reverting TP53 Mutation in Breast Cancer Cells: Prime Editing Workflow and Technical Considerations
Abuhamad, A. Y., Zamberi, N. N. M., Ling, S., Naes, S. M., Yusuf, S. N. H. M., Tajudin, A. A., Mohtar, M. A., Syahir, A., & Syafruddin, S. E. (2022) · Cells · doi:10.3390/cells11101612 · Cited by 20
CRISPR Technology and Its Emerging Applications
Zhang, X. E., Ma, D., & Liu, F. (2025) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzaf034 · Cited by 21
The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold?
Oliver, K. E., Carlon, M. S., Pedemonte, N., & Lopes‐Pacheco, M. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2230129 · Cited by 19
Celotti, M., Derks, L. L. M., van Es, J., van Boxtel, R., Clevers, H., & Geurts, M. H. (2024) · STAR Protocols · doi:10.1016/j.xpro.2024.103189 · Cited by 17
Self-citationGene Editing in Pluripotent Stem Cells and Their Derived Organoids
Zhou, H., Wang, Y., Liu, L., Li, Y., & Zheng, Y. (2021) · Stem Cells International · doi:10.1155/2021/8130828 · Cited by 18
Joynt, A. T., Kavanagh, E. W., Newby, G. A., Mitchell, S., Eastman, A. C., Paul, K. C., Bowling, A. D., Osorio, D. L., Merlo, C. A., Patel, S. U., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.06.020 · Cited by 16
New Directions in Pulmonary Gene Therapy
Vu, A., & McCray, P. B. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.166 · Cited by 19
Nicosia, L., Pranke, I. M., Latorre, R. V., Murray, J. B., Lonetti, L., Cavusoglu-Doran, K., Dréano, E., Costello, J. P., Carroll, M. A., Melotti, P., et al. (2025) · iScience · doi:10.1016/j.isci.2025.111979 · Cited by 17
HIV cure strategies: which ones are appropriate for Africa?
Abana, C. Z.-Y., Lamptey, H., Bonney, E. Y., & Kyei, G. B. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04421-z · Cited by 16
Mention, K., Cavusoglu-Doran, K., Joynt, A. T., Santos, L., Sanz, D. J., Eastman, A. C., Merlo, C. A., Langfelder-Schwind, E., Scallan, M. F., Farinha, C. M., et al. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad143 · Cited by 17
Rewriting CFTR to cure cystic fibrosis
Maule, G., Ensinck, M. M., Bulcaen, M., & Carlon, M. S. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.12.018 · Cited by 17
CRISPR base editing applications for identifying cancer-driving mutations
Pál, M., & Herold, M. J. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200550 · Cited by 17
Correction of the pathogenic mutation in TGM1 gene by adenine base editing in mutant embryos
Dang, L., Zhou, X., Zhong, X., Yu, W., Huang, S., Liu, H., Chen, Y., Zhang, W., Yuan, L., Li, L., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.05.007 · Cited by 16
Exploring the therapeutic potential of modulating nonsense-mediated mRNA decay
McMahon, M., & Maquat, L. E. (2024) · RNA · doi:10.1261/rna.080334.124 · Cited by 16
Nonsense Mutations in Rare and Ultra‐Rare Human Disorders: An Overview
Vitale, E., Ricci, D., Corrao, F., Fiduccia, I., Cruciata, I., Carollo, P. S., Branchini, A., Lentini, L., & Pibiri, I. (2025) · IUBMB Life · doi:10.1002/iub.70031 · Cited by 15
Metadata
- Authors
- Geurts, M. H., de Poel, E., Amatngalim, G. D., Oka, R., Meijers, F. M., Kruisselbrink, E., van Mourik, P., Berkers, G., de Winter-de Groot, K. M., Michel, S., Muilwijk, D., Aalbers, B. L., Mullenders, J., Boj, S. F., Suen, S. W. F., Brunsveld, J. E., Janssens, H. M., Mall, M. A., Graeber, S. Y., van Boxtel, R., van der Ent, C. K., Beekman, J. M., & Clevers, H.
- Affiliations
- Royal Netherlands Academy of Arts and Sciences (NL)
- Utrecht University (NL)
- Oncode Institute (NL)
- Erasmus MC (NL)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Corresponding author
- Beekman, Jeffrey M.
- Clevers, Hans
- ORCID
- Venue
- Cell Stem Cell
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 26
- Issue
- 4
- Pages
- 503-510.e7
- ISSN
- 1875-9777 (ISSN-L)
- 1934-5909
- OpenAlex
- W3007694991
- Cited by
- 222
- References
- 46
- Citations by year
- 2026: 19 · 2025: 33 · 2024: 31 · 2023: 37 · 2022: 33 · 2021: 44 · 2020: 25
- FWCI
- 11.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell stem cell (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (submittedVersion)
- Funders
- Cancer Research UK (C6307/A29058)
- Charité – Universitätsmedizin Berlin
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (737.016.009)
- Berlin Institute of Health
- Nederlandse Cystic Fibrosis Stichting
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- adenine base editing, cystic fibrosis, nonsense mutation, intestinal organoids, organoid biobank, gene correction, off-target mutations, genetic disorders, patient-derived cells
- MeSH terms
- Gene Editing, CRISPR-Associated Protein 9, Adenine, Cystic Fibrosis, Humans, Organoids, Biological Specimen Banks, Codon, Nonsense, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
